Murphy is a well-respected investor newsletter writer. His claim to fame was making the right call on biotech behemoths Amgen, Biogen, and Genentech (recently bought out by Roche).
http://seekingalpha.com/instablog/128006-michael-murphy/1133-dendreon-a-360-stock-or-is-that-too-low
He's obviously bullish on DNDN, but a peak into his newsletter reveals he's also bullish on MELA and ARNA.
Do your due diligence and good luck.
Disclosure: I am long DNDN and ARNA.
Monday, April 20, 2009
Subscribe to:
Post Comments (Atom)
Posts
![[Most Recent Quotes from www.kitco.com]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_uGNZaR-0VCJdtOmR8jej14hEW9NETx78wgYrbHDU5OuxTB1NjnLNK6Uwl6IGiX88B1aYpW1w3kkDcfhEOZpKBFTYFqwJwawU85FONpJfOPfDl24LFlmZJCVqrn_JjPVabeew=s0-d)
![[Most Recent Quotes from www.kitco.com]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_tApDX_ET1tTErSUlhuRtErohhIBC1pFl-Dt7oVNcQ0bQsYK9rCiinAkj_jpjlBvDyQvFsLszwSvtsL9TtRoEDXXil5ODsdy6DjjQJFM45wXBzIEyP1A9WtUogSxSqyshfwy7Fo=s0-d)
![[Most Recent USD from www.kitco.com]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_tQEX9da-RWclkDAtcp0scf16RT0E6J-oW3BrOG4wALAkxNTEok1qsAJqU19H_ROI4s9o75Ju2Et719NlDFDevDmlTdl_8iCD30il1ZpscMHO1CyCEl_FfL=s0-d)
No comments:
Post a Comment